Showing 1121-1130 of 23044 results for "".
Service Excellence
https://reachmd.com/programs/clinicians-roundtable/service-excellence-1-1/1041/Dr. Michael Greenberg hosts Dr. Victor Marks of the Geisinger Clinic in Danville, PA, in a discussion of how a focus on service excellence can create happier patients and more satisfied doctors.The Cell Death Pathway: Leveraging Glioblastoma Treatments
https://reachmd.com/programs/neurofrontiers/the-cell-death-pathway-leveraging-glioblastoma-treatments/15111/What role does nutrition have in treating patients with glioblastoma? Tune in for details on a new cell death pathway that could potentially treat tumor cells.Leveraging AI To Optimize Epilepsy Patient Care
https://reachmd.com/programs/practical-neurology/leveraging-ai-to-optimize-epilepsy-patient-care/39906/Pierre D’Haese, PhD, West Virginia University Rockefeller Neuroscience Institute, Morgantown, WV, discuses how AI-driven automation can surface missing MRIs, EEGs, and neuropsychological evaluations to close diagnostic care gaps in epilepsy management.Reimagining Autoimmune Care with CAR-Based Cell Therapies
https://reachmd.com/programs/living-rheum/reimagining-autoimmune-care-with-car-based-cell-therapies/32815/Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/advancing-patient-centered-care-in-her2-positive-metastatic-breast-cancer/35461/When treating patients with metastatic breast cancer, effective communication and patient support are key. Join Dr. Megan Kruse, a medical oncologist at Cleveland Clinic in Ohio, as she explains how to align treatment goals with patient values, address physical and emotional needs through multidisciImmune Cells: Are They the Key to Better Allergy and Infection Therapies?
https://reachmd.com/programs/primary-care-today/immune-cells-are-they-key-better-allergy-and-infection-therapies/9824/Dr. Avery August talks about the molecular and fundamental mechanisms behind allergic reactions and autoimmunity.COVID-19 Reflections: How to Address Vaccine Messaging and Public Health Challenges
https://reachmd.com/programs/clinicians-roundtable/covid-19-reflections-how-to-address-vaccine-messaging-and-public-health-challenges/29091/Here to share his perspective on how we can address the public health challenges stemming from the COVID-19 pandemic is Dr. Aslam Khan.An Epidemic Amid a Pandemic: CVD, COVID-19, & the Leading Cause of Death Worldwide
https://reachmd.com/programs/heart-matters/an-epidemic-among-a-pandemic-cvd-covid-19-the-leading-cause-of-death-worldwide/12286/With rising COVID-19 fatalities, heart disease may no longer be the leading cause of the death worldwide.Data Analytics in CME: Bringing Quality Improvement to the Next Level
https://reachmd.com/programs/lifelong-learning/data-analytics-cme-bringing-quality-improvement-next-level/7955/Lauren Patrick, President of Healthmonix, joins host Alicia Sutton on the floors of the ACEhp annual meeting to discuss customized, collaborative models in quality improvement, and how new perspectives on data analytics are changing assessments of clinical performance improvement.Personalized Diagnostics & Targeted Therapies
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/personalized-diagnostics-targeted-therapies/6954/The Philadelphia Chromosome provided the first evidence that genetic abnormalities were linked to cancer. This discovery at Penn Medicine more than 50 years ago ushered in the modern period of cytogenetics. Now, the Center for Personalized Diagnostics (CPD) builds on this legacy and is set to pave t